Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers

被引：0
|
作者：
Henk van der Poel
Laurence Klotz
Gerald Andriole
Abdel-Rahmène Azzouzi
Anders Bjartell
Olivier Cussenot
Freddy Hamdy
Markus Graefen
Paolo Palma
Arturo Rodriguez Rivera
Christian G. Stief
机构：
[1] Netherlands Cancer Institute,Department of Urology
[2] University of Toronto,Division of Urology, Sunnybrook Health Science Centre
[3] Washington University St Louis,Division of Urology, Department of Surgery
[4] CHU d’Angers,Service d’Urologie
[5] Sahlgrenska Academy at the University of Gothenburg,Department of Urology, Institute of Clinical Sciences
[6] UPMC Univ Paris 06,Institute Universitaire de Cancerologie
[7] GRC-05,Nuffield Department of Surgical Sciences
[8] ONCOTYPE-Uro,Martini
[9] University of Oxford,Clinic Prostate Cancer Center
[10] University Medical Center Hamburg-Eppendorf,Department of Urology
[11] Universidade Estadual de Campinas,Department of Urology, Klinikum Großhadern, University Hospital Munich
[12] Hospital General Tlahuac,Großhadern
[13] Ludwig-Maximillians-University München,undefined
来源：
World Journal of Urology | 2015年 / 33卷
关键词：
Prostate cancer; Focal therapy; Active surveillance; Low risk; Intermediate risk; Consensus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：907 / 916
页数：9
相关论文
共 50 条
  • [31] Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approach
    Michael Baboudjian
    Alberto Breda
    Thierry Roumeguère
    Alessandro Uleri
    Jean-Baptiste Roche
    Alae Touzani
    Vito Lacetera
    Jean-Baptiste Beauval
    Romain Diamand
    Guiseppe Simone
    Olivier Windisch
    Daniel Benamran
    Alexandre Fourcade
    Gaelle Fiard
    Camille Durand-Labrunie
    Mathieu Roumiguié
    Francesco Sanguedolce
    Marco Oderda
    Eric Barret
    Gaëlle Fromont
    Charles Dariane
    Anne-Laure Charvet
    Bastien Gondran-Tellier
    Cyrille Bastide
    Eric Lechevallier
    Joan Palou
    Alain Ruffion
    Roderick C. N. Van Der Bergh
    Alexandre Peltier
    Guillaume Ploussard
    World Journal of Urology, 2023, 41 : 1301 - 1308
  • [32] Active Surveillance for Intermediate Risk Prostate Cancer
    Laurence Klotz
    Current Urology Reports, 2017, 18
  • [33] Active Surveillance for Intermediate Risk Prostate Cancer
    Klotz, Laurence
    CURRENT UROLOGY REPORTS, 2017, 18 (10)
  • [34] ACTIVE SURVEILLANCE IN INTERMEDIATE RISK PROSTATE CANCER
    Chandrasekar, Thenappan
    Herrera-Caceres, Jaime O.
    Klotz, Laurence
    ARCHIVOS ESPANOLES DE UROLOGIA, 2019, 72 (02): : 157 - 166
  • [35] Navigating the evolving diagnostic and therapeutic landscape of low- and intermediate-risk prostate cancer
    Zattoni, Fabio
    Matrone, Fabio
    Bortolus, Roberto
    Giannarini, Gianluca
    ASIAN JOURNAL OF ANDROLOGY, 2024, 26 (06): : 549 - 556
  • [36] Active Surveillance in Prostate Cancer With Intermediate-Risk Features: The PRIAS-JAPAN Study
    Blas, Leandro
    Shiota, Masaki
    Kato, Takuma
    Matsumoto, Ryuji
    Tohi, Yoichiro
    Sakamoto, Shinichi
    Yokomizo, Akira
    Kimura, Takahiro
    Furukawa, Junya
    Shoji, Sunao
    Kume, Haruki
    Goto, Takayuki
    Sekine, Yoshitaka
    Sakai, Yasuyuki
    Matsuoka, Yoh
    Hinata, Nobuyuki
    Kamoto, Toshiyuki
    Terada, Naoki
    Akamatsu, Shusuke
    Sugimoto, Mikio
    Eto, Masatoshi
    INTERNATIONAL JOURNAL OF UROLOGY, 2025,
  • [37] Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy
    Cheung, R
    Tucker, SL
    Lee, AK
    De Crevoisier, R
    Dong, L
    Kamat, A
    Pisters, L
    Kuban, D
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (04): : 993 - 1002
  • [38] Results of active surveillance in low and intermediate risk prostate cancer
    Llorente, Carlos
    Diaz Goizueta, Francisco Javier
    Hernandez, Virginia
    Manuel de la Morena, Jose
    de la Pena, Enrique
    ARCHIVOS ESPANOLES DE UROLOGIA, 2014, 67 (05): : 452 - 456
  • [39] Longitudinal regret after treatment for low- and intermediate-risk prostate cancer
    Hurwitz, Lauren M.
    Cullen, Jennifer
    Kim, Daniel J.
    Elsamanoudi, Sally
    Hudak, Jane
    Colston, Maryellen
    Travis, Judith
    Kuo, Huai-Ching
    Rice, Kevin R.
    Porter, Christopher R.
    Rosner, Inger L.
    CANCER, 2017, 123 (21) : 4252 - 4258
  • [40] Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
    Kim, Hun Jung
    Phak, Jeong Hoon
    Kim, Woo Chul
    RADIATION ONCOLOGY JOURNAL, 2016, 34 (04): : 260 - 264
12345